Diven, Marshall
Ballman, Karla
Marciscano, Ariel
Barbieri, Christopher
Piscopo, Jennifer
Wang, Shu
Nagar, Himanshu
McClure, Timothy
Article History
Received: 15 March 2024
Accepted: 4 June 2024
First Online: 25 July 2024
Declarations
:
: The study is approved by the Institutional Review Board (IRB) of Weill Cornell Medicine (IRB Protocol #:22-03024562). The IRB- approved protocol and study data are reviewed by the Weill Cornell Medicine Data and Safety Monitoring Board. The methods in this study are implemented in accordance with all guidelines and regulations, including the Declaration of Helskink and the Weil Cornell Medicine Data and Safety Monitoring Plan. Prior to participation in the study, informed consent will be obtained from all potential participants and/or their legal guardians. Appropriately consented patients eligibility for the trial are reviewed and signed off by treating physicians prior to enrollment on the Weill Cornell Medicine Clinical Trial Management System.
: Not applicable.
: The authors declare no competing interests.